Labyrinthulomycete Strains for Sustainable DHA Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing omega-3 fatty acids, such as docosahexaenoic acid (DHA), from fish oils are unsustainable due to overfishing and contamination issues, and alternative microbial sources like chytrids are costly. There is a need for strains with enhanced DHA production rates to reduce costs.
Innovation Solution
Development of novel labyrinthulomycete microorganisms with improved DHA production capabilities, including strains deposited with the Agricultural Research Service Culture Collection, which can produce at least 25% of fatty acids as DHA, and methods for isolating derivative strains through mutagenesis and selection in cytostats or chemostats, enhancing lipid productivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fish oils are used as the source of omega-3 fatty acids, then the production cost is low, but the method is unsustainable due to overfishing and heavy metal contamination
Solution Approach 1:
The patent replaces sustainable but expensive microbial sources with a disposable fish oil source that can be processed quickly, accepting the environmental cost as a temporary measure while developing alternative microbial strains for long-term sustainability
Solution Approach 2:
The invention changes the source parameter from fish-derived to microbially-derived omega-3 fatty acids, transforming the production system from unsustainable to sustainable while managing the transition cost through strain selection and optimization
2Reliability
If microbial sources like chytrids are used to produce DHA sustainably, then sustainability is improved, but the production cost becomes high
Solution Approach 1:
The patent changes the microbial strain parameter from conventional chytrids to newly isolated labyrinthulomycete strains with superior DHA production characteristics, altering the cost-performance parameter by achieving higher productivity that offsets the increased cultivation complexity
Solution Approach 2:
The invention creates derivative strains through mutagenesis and selection processes, producing multiple variants that can be optimized for different production conditions, thereby reducing overall manufacturing costs through strain selection rather than process modification
3Productivity
If conventional chytrid strains are used for DHA production, then the process is established and reliable, but the DHA production rate is low
Solution Approach 1:
The patent performs preliminary strain isolation, characterization, and deposition in culture collections before full-scale production implementation, ensuring process reliability is established through thorough pre-screening and validation of the novel labyrinthulomycete strains
Solution Approach 2:
The invention implements a feedback mechanism through continuous strain improvement programs using mutagenesis and selection in cytostats/chemostats, allowing the production system to evolve and increase DHA rates while maintaining stability through controlled selection pressure
4Productivity
If strain improvement through mutagenesis and selection is implemented, then DHA production is enhanced, but the process complexity increases
Solution Approach 1:
The patent develops a universal strain improvement platform using mutagenesis and selection techniques in cytostats or chemostats that can be applied to multiple labyrinthulomycete strains simultaneously, reducing per-strain complexity while achieving enhanced lipid productivity across the strain collection
Data Source
AI summary
Improved labyrinthulomycetes strains that produce microbial oils having increased docosahexaenoic acid (DHA) content are disclosed. The strains have increased productivity with respect to a wild type strain. Also provided are microbial oil compositions having increased DHA content. Methods of improving strains for the production of lipid, such as DHA, are also included.